BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 25582421)

  • 1. The Diagnostic Value of Transvaginal Sonograph (TVS), Color Doppler, and Serum Tumor Marker CA125, CEA, and AFP in Ovarian Cancer.
    Zhang F; Zhang ZL
    Cell Biochem Biophys; 2015 Jun; 72(2):353-7. PubMed ID: 25582421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on angiogenesis in the benign and malignant ovarian neoplasms with the use of color and pulsed Doppler sonography and serum CA-125, CA-19.9, CA-72.4 and vascular endothelial growth factor measurements.
    Czekierdowski A
    Ann Univ Mariae Curie Sklodowska Med; 2002; 57(1):113-31. PubMed ID: 12898913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the importance of the serum levels of CA-125, CA15-3, CA-19-9, carcinoembryonic antigen and alpha fetoprotein for distinguishing benign and malignant adnexal masses and contribution of different test combinations to diagnostic accuracy.
    Bozkurt M; Yumru AE; Aral I
    Eur J Gynaecol Oncol; 2013; 34(6):540-4. PubMed ID: 24601047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative detection of ovarian cancer by color Doppler ultrasonography and CA 125.
    Hossain F; Karim MN; Rahman SM; Khan N; Siddiqui M; Hussain R
    Bangladesh Med Res Counc Bull; 2010 Aug; 36(2):68-73. PubMed ID: 21473205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Program for early detection of ovarian cancer for women as prophylaxis provided at a municipal hospital].
    Cnota W; Sodowski K; Olesiak-Andryszczak M; Pilch-Kowalczyk M
    Wiad Lek; 2004; 57 Suppl 1():43-7. PubMed ID: 15884203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of transvaginal color Doppler sonography, transvaginal sonography and CA 125 for prediction of ovarian malignancy.
    Sengoku K; Satoh T; Saitoh S; Abe M; Ishikawa M
    Int J Gynaecol Obstet; 1994 Jul; 46(1):39-43. PubMed ID: 7805982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Value of color Doppler ultrasonography, contrast-enhanced ultrasound and serum CA-125 detection in differential diagnosis of ovarian masses].
    Zhou Q; Liu BL; Jiang J; Lei XY
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Oct; 29(10):2007-9. PubMed ID: 19861251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of CA125/CEA ratio and ultrasound parameters in identifying metastases to the ovaries in patients with multilocular and multilocular-solid ovarian masses.
    Moro F; Pasciuto T; Djokovic D; Di Legge A; Granato V; Moruzzi MC; Mancari R; Zannoni GF; Fischerova D; Franchi D; Scambia G; Testa AC
    Ultrasound Obstet Gynecol; 2019 Jan; 53(1):116-123. PubMed ID: 29978587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CEA in evaluation of adnexal mass: retrospective cohort analysis and review of the literature.
    Sagi-Dain L; Lavie O; Auslander R; Sagi S
    Int J Biol Markers; 2015 Nov; 30(4):e394-400. PubMed ID: 26109367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on ovarian cancer screening.
    Munkarah A; Chatterjee M; Tainsky MA
    Curr Opin Obstet Gynecol; 2007 Feb; 19(1):22-6. PubMed ID: 17218847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discrimination between benign and malignant adnexal masses by specialist ultrasound examination versus serum CA-125.
    Van Calster B; Timmerman D; Bourne T; Testa AC; Van Holsbeke C; Domali E; Jurkovic D; Neven P; Van Huffel S; Valentin L
    J Natl Cancer Inst; 2007 Nov; 99(22):1706-14. PubMed ID: 18000221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical performance of LOCI™-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and AFP in gynecological cancers.
    Dolscheid-Pommerich RC; Keyver-Paik M; Hecking T; Kuhn W; Hartmann G; Stoffel-Wagner B; Holdenrieder S
    Tumour Biol; 2017 Oct; 39(10):1010428317730246. PubMed ID: 29034816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transvaginal color Doppler sonography and conventional sonography in the preoperative assessment of adnexal masses.
    Reles A; Wein U; Lichtenegger W
    J Clin Ultrasound; 1997 Jun; 25(5):217-25. PubMed ID: 9314102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor markers in serum and ascites in the diagnosis of benign and malignant ascites.
    Zhu FL; Ling AS; Wei Q; Ma J; Lu G
    Asian Pac J Cancer Prev; 2015; 16(2):719-22. PubMed ID: 25684514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sonographic characterization, Doppler ultrasonography and tumor markers in the diagnosis of malignancy of ovarian masses].
    Gramellini D; Rutolo S; Verrotti C; Piantelli G; Fieni S; Vadora E
    Minerva Ginecol; 2001 Feb; 53(1):1-11. PubMed ID: 11279390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Value of transvaginal color Doppler flow imaging conjugated with multiple serum tumor markers in diagnosis of ovarian tumors].
    Wang Y; Liu LZ; Zhou JH; Pei XQ; Chen XY
    Ai Zheng; 2004 Nov; 23(11 Suppl):1585-8. PubMed ID: 15566685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Usefulness of clinical evaluation for the level of CA-125 antigen and ultrasonographic color Doppler examination in diagnosis of ovarian tumor].
    Czekierdowski A; Zrubek H; Sikorski M; Wiktor H; Józefczak M; Stachowicz N
    Ginekol Pol; 1996 Nov; 67(11):552-6. PubMed ID: 9289441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimation of probability of malignancy using a logistic model combining color Doppler ultrasonography, serum CA125 level in women with a pelvic mass.
    Mousavi AS; Borna S; Moeinoddini S
    Int J Gynecol Cancer; 2006; 16 Suppl 1():92-8. PubMed ID: 16515574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined use of AFP, CEA, CA125 and CAl9-9 improves the sensitivity for the diagnosis of gastric cancer.
    He CZ; Zhang KH; Li Q; Liu XH; Hong Y; Lv NH
    BMC Gastroenterol; 2013 May; 13():87. PubMed ID: 23672279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Transvaginal color doppler ultrasonography and CA125 detection in surveillance of ovarian malignant tumors after operation].
    Zeng H; Pei XQ; Zheng DM; Zhao YL; Chen XY
    Ai Zheng; 2006 Oct; 25(10):1296-9. PubMed ID: 17059780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.